These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 15472471

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein.
    Takara K, Tanigawara Y, Komada F, Nishiguchi K, Sakaeda T, Okumura K.
    Jpn J Cancer Res; 2000 Feb; 91(2):248-54. PubMed ID: 10761713
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Human P-glycoprotein as a multi-drug transporter analyzed by using transepithelial transport system.
    Ueda K, Saeki T, Hirai M, Tanigawara Y, Tanaka K, Okamura M, Yasuhara M, Hori R, Inui K, Komano T.
    Jpn J Physiol; 1994 Feb; 44 Suppl 2():S67-71. PubMed ID: 7538609
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of P-glycoprotein inhibitors on cadmium accumulation in cultured renal epithelial cells, LLC-PK1, and OK.
    Endo T, Kimura O, Sakata M.
    Toxicol Appl Pharmacol; 2002 Dec 15; 185(3):166-71. PubMed ID: 12498733
    [Abstract] [Full Text] [Related]

  • 27. Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells.
    Tahara K, Kagawa Y, Takaai M, Taguchi M, Hashimoto Y.
    Drug Metab Pharmacokinet; 2008 Dec 15; 23(5):340-6. PubMed ID: 18974611
    [Abstract] [Full Text] [Related]

  • 28. $3,3',4,4',5$ -Pentachlorobiphenyl Inhibits Drug Efflux Through P-Glycoprotein in KB-3 Cells Expressing Mutant Human P-Glycoprotein.
    Fujise H, Sasawatari S, Annoura T, Ikeda T, Ueda K.
    J Biomed Biotechnol; 2004 Dec 15; 2004(3):137-142. PubMed ID: 15292579
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein.
    Wandel C, Kim R, Wood M, Wood A.
    Anesthesiology; 2002 Apr 15; 96(4):913-20. PubMed ID: 11964599
    [Abstract] [Full Text] [Related]

  • 31. Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus.
    Wang R, Sun X, Deng YS, Qiu XW.
    Xenobiotica; 2019 Nov 15; 49(11):1373-1378. PubMed ID: 30587068
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Haloperidol is an inhibitor but not substrate for MDR1/P-glycoprotein.
    Iwaki K, Sakaeda T, Kakumoto M, Nakamura T, Komoto C, Okamura N, Nishiguchi K, Shiraki T, Horinouchi M, Okumura K.
    J Pharm Pharmacol; 2006 Dec 15; 58(12):1617-22. PubMed ID: 17331325
    [Abstract] [Full Text] [Related]

  • 34. Evidence for the involvement of P-glycoprotein on the extrusion of taken up L-DOPA in cyclosporine A treated LLC-PK1 cells.
    Soares-da-Silva P, Serrão MP, Vieira-Coelho MA, Pestana M.
    Br J Pharmacol; 1998 Jan 15; 123(1):13-22. PubMed ID: 9484849
    [Abstract] [Full Text] [Related]

  • 35. P-glycoprotein-mediated transcellular transport of MDR-reversing agents.
    Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T.
    FEBS Lett; 1993 Jun 07; 324(1):99-102. PubMed ID: 8099333
    [Abstract] [Full Text] [Related]

  • 36. Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1.
    Takeuchi T, Yoshitomi S, Higuchi T, Ikemoto K, Niwa S, Ebihara T, Katoh M, Yokoi T, Asahi S.
    Pharm Res; 2006 Jul 07; 23(7):1460-72. PubMed ID: 16779700
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1.
    Ito T, Yano I, Tanaka K, Inui KI.
    J Pharmacol Exp Ther; 1997 Aug 07; 282(2):955-60. PubMed ID: 9262363
    [Abstract] [Full Text] [Related]

  • 39. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells.
    Salama NN, Yang Z, Bui T, Ho RJ.
    J Pharm Sci; 2006 Oct 07; 95(10):2293-308. PubMed ID: 16883550
    [Abstract] [Full Text] [Related]

  • 40. Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): comparison of rat P-glycoprotein transport to human and mouse.
    Booth-Genthe CL, Louie SW, Carlini EJ, Li B, Leake BF, Eisenhandler R, Hochman JH, Mei Q, Kim RB, Rushmore TH, Yamazaki M.
    J Pharmacol Toxicol Methods; 2006 Oct 07; 54(1):78-89. PubMed ID: 16545584
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.